BACKGROUND Intrauterine insemination with ovarian stimulation (IUI-OS) is a first-line
treatment for unexplained infertility. Gonadotrophins, letrozole and clomiphene citrate (CC) …

ABSTRACT BACKGROUND IUI for unexplained infertility can be performed in a natural
cycle or in combination with ovarian stimulation. A disadvantage of ovarian stimulation is an …

Abstract BACKGROUND IVF and IUI with ovarian stimulation (IUI-OS) are widely used in
managing unexplained infertility. IUI-OS is generally considered first-line therapy, followed …

Objective To compare live birth and multiple gestation in patients diagnosed with
unexplained infertility undergoing intrauterine insemination after ovarian stimulation (OS-IUI) …

Objective To provide evidence-based recommendations to practicing physicians and others
regarding the effectiveness and safety of therapies for unexplained infertility. Methods ASRM …

Research question What is the cost-effectiveness of gonadotrophins compared with
clomiphene citrate in couples with unexplained subfertility undergoing intrauterine …

Objective To identify baseline characteristics of couples that are likely to predict conception,
clinical pregnancy, and live birth after up to four cycles of ovarian stimulation with IUI in …

Over the past 15 years, there has been a marked increase in the use of ovulation induction
and intrauterine insemination (IUI) for the treatment of unexplained infertility. However …

Background IUI+ COH is widely used in cases of unexplained infertility before resorting to
IVF. Debate continues about what should be the first-line treatment for couples with …

STUDY QUESTION Which agent for ovarian stimulation (OS) is the most cost-effective option
in terms of net benefit for couples with unexplained subfertility undergoing IUI? SUMMARY …